Gilead Sciences, Inc. (GILD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 65.46 |
| Open | 65.57 |
| Bid | 64.88 x 800 |
| Ask | 64.91 x 800 |
| Day's range | 64.76 - 65.58 |
| 52-week range | 64.33 - 87.87 |
| Volume | |
| Avg. volume | 7,199,713 |
| Market cap | 80.953B |
| Beta (5Y monthly) | 0.23 |
| PE ratio (TTM) | 180.33 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.08 (4.74%) |
| Ex-dividend date | 14 Jun 2024 |
| 1y target est | N/A |
- GuruFocus.com
Decoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight
Unraveling the Financial Dynamics and Strategic Directions of Gilead Sciences Inc (GILD)
- Insider Monkey
23 Most Profitable Stocks of the Last 12 Months
In this article, we discuss the 23 most profitable stocks of the last 12 months. If you want to skip our detailed analysis of these stocks, go directly to 5 Most Profitable Stocks of the Last 12 Months. The United States stock market has come a long way since the turn of the millennium more […]
- Zacks
The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine are included in this Analyst Blog.
© 2024 Yahoo. All rights reserved.